Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.36 |
| ▸ | PPARA | Q07869 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1122756 | 0.77 | KMT2A (0.55) | MEN1KMT2A | |
| SCHEMBL5720725 | 0.74 | KMT2A (0.42) | LMNATP53F2MEN1KMT2A | |
| SCHEMBL1122848 | 0.72 | LMNA (0.46) | F10LMNATP53MEN1KMT2A | |
| SCHEMBL1122939 | 0.72 | KMT2A (0.45) | LMNATP53MEN1KMT2APPARG | |
| SCHEMBL1123174 | 0.69 | NR4A2 (0.59) | LMNASLC2A1PPARAKMT2AFFAR1 | |
| SCHEMBL1123197 | 0.67 | MEN1 (0.43) | MEN1KMT2APPARG | |
| SCHEMBL1123406 | 0.67 | NR4A2 (0.56) | LMNASLC2A1KMT2ATSHRFFAR1 | |
| SCHEMBL1122914 | 0.67 | KMT2A (0.51) | F10SLC2A1PPARAKMT2APPARG | |
| SCHEMBL1123277 | 0.67 | PPARG (0.49) | F10SLC2A1PPARAMEN1KMT2A | |
| SCHEMBL1123189 | 0.66 | LPAR1 (0.51) | F10SLC2A1PPARAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | disclosed |
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | F10 4518/4885LMNA 1251/4885TP53 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.